Kamran Ahmed Khan

Dr. Kamran Ahmed Khan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Open access
PDF file
KKKamran Ahmed Khan
Kamran Ahmed Khan
NQNadeem Qamar
Nadeem Qamar
TSTahir Saghir
Tahir Saghir
JSJawaid Akbar Sial
Jawaid Akbar Sial
DKDileep Kumar
Dileep Kumar
MKMusa Karim
Musa Karim
Background: Intracoronary epinephrine has been effectively used in treating refractory no-reflow, but there is a dearth of data on its use as a first-line drug in normotensive patients in comparison to the widely used adenosine. Methods: In this open-labeled randomized clinical trial, 201 patients with no-reflow were randomized 1:1 into intracoronary epinephrine as the treatment group and intracoronary adenosine as the control group and followed for 1 month. The primary end points were improvement in coronary flow, as assessed by TIMI (Thrombolysis in Myocardial Infarction) flow, frame counts, and myocardial blush. Secondary end points were in-hospital and short-term mortality and major adverse cardiac events. Results: In all, 101 patients received intracoronary epinephrine and 100 patients received adenosine. Epinephrine was generally well tolerated with no immediate table death or ventricular fibrillation. No-reflow was more effectively improved with epinephrine with final TIMI III flow (90.1% versus 78%, P =0.019) and final corrected TIMI frame count (24±8.43 versus 26.63±9.22, P =0.036). However, no significant difference was observed in final grade III myocardial blush (55.4% versus 45%, P =0.139), mean reduction of corrected TIMI frame count (−25.71±11.79 versus −26.08±11.71, P =0.825), in-hospital and short-term mortality, and major adverse cardiac events. Conclusions: Epinephrine is relatively safe to use in no-reflow in normotensive patients. A significantly higher frequency of post-treatment TIMI III flow grade and lower final corrected TIMI frame count with relatively better achievement of myocardial blush grade III translate into it displaying relatively better efficacy than adenosine. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04699110.

16 March 2022 in The American Journal of Cardiology
Verified
Journal Article
Open access
RKRajesh Kumar
Rajesh Kumar
AAAli Ammar
Ali Ammar
TSTahir Saghir
Tahir Saghir
JSJawaid Akbar Sial
Jawaid Akbar Sial
KKKamran Ahmed Khan
Kamran Ahmed Khan
MKMusa Karim
Musa Karim
In this study, we developed and validated a novel risk stratification model to predict slow-flow/no-reflow (SF/NR) during the primary percutaneous coronary intervention (PCI), namely the RK-SF/NR score. A total of 1,711 consecutive patients with ST-segment elevation myocardial infarction (STEMI) undergone primary PCI. A novel risk stratification model was developed in the development dataset and tested in the validation dataset. The overall incidence rate of SF/NR during the procedure was 28.8% (493/1,711). The final solution consisted of 9 variables: female gender (points = 2), total ischemic time ≥8 hours (points = 1), cardiac arrest at presentation (points = 2), left ventricular end-diastolic pressure ≥24 mm Hg (points = 3), left ventricular ejection fraction ≤30% (points = 2), culprit proximal left anterior descending artery (points = 3), thrombus grade ≥4 (points = 6), preprocedure thrombolysis in myocardial infarction (TIMI) 0 flow (points = 2), and lesion length ≥35 mm (points = 3). In the validation set, the area under the curve the RK-SF/NR score was 0.775 (0.722 to 0.829) and a score ≥10 has sensitivity of 77.9% (68.2% to 85.8%), negative predictive value of 87.3% (82.3% to 91.0%), specificity of 62.6% (56.0% to 68.9%), and positive predictive value of 46.3% (41.4% to 51.2%). In conclusion, RK-SF/NR score had shown good discriminating power for predicting SF/NR during primary PCI with good sensitivity and negative predictive value. Hence, the proposed model can have good clinical utility for screening patients at high risk of developing SF/NR during primary PCI.

1 January 2022 in Sage Open Medicine
Verified
Journal Article
Open access
KKKamran Ahmed Khan
Kamran Ahmed Khan
RKRajesh Kumar
Rajesh Kumar
JSJehangir Ali Shah
Jehangir Ali Shah
FFFawad Farooq
Fawad Farooq
QSQuratulain Shaikh
Quratulain Shaikh
MKMusa Karim
Musa Karim
Objectives: No-reflow is a complication that frequently occurs after stenting during primary percutaneous coronary intervention. In this study, we focused on angiographic results and clinical outcomes after no-reflow in the left anterior descending (LAD) artery versus non–left anterior descending artery ST-elevation myocardial infarction (STEMI). Methods: In this prospective study, a total of 201 patients who had developed no-reflow during primary percutaneous coronary intervention were enrolled. The patients were divided into left anterior descending artery culprit and non-left anterior descending artery culprit groups. The primary endpoints were final thrombolysis in myocardial infarction flow, corrected thrombolysis in myocardial infarction frame count and final myocardial blush grade. Secondary endpoints were major adverse cardiovascular events in-hospital and at 1 month. Results: Out of the 201 patients, 60.19% had culprit left anterior descending artery. Pulse rate, baseline systolic and diastolic blood pressure, single-vessel disease, left ventricular ejection fraction 40% were significantly greater in the non–left anterior descending artery group. However, for both in-hospital and at 30 days, overall major adverse cardiovascular event was similar in the two groups. The demographics, clinical and medication profiles and the routes used to treat no-reflow were all comparable in both groups. Conclusions: No-reflow in left anterior descending artery ST-elevation myocardial infarction is associated with lower final thrombolysis in myocardial infarction III flow, higher thrombolysis in myocardial infarction frame count and relatively lower Grade III myocardial blush than non-left anterior descending artery ST-elevation myocardial infarction with subsequent lower left ventricular ejection fraction and a higher frequency of in-hospital heart failure and hospitalisation due to heart failure.

30 July 2025 in JACC: Case Reports
Verified
Journal Article
Open access
ANAli Hyder Nazeer
Ali Hyder Nazeer
AHAbdul Hameed
Abdul Hameed
IBIram Jehan Balouch
Iram Jehan Balouch
KBKhalid Iqbal Bhatti
Khalid Iqbal Bhatti
KKKamran Ahmed Khan
Kamran Ahmed Khan
Stent dislodgement during percutaneous coronary intervention (PCI) is a feared complication, associated with coronary tortuosity and calcifications. Similarly, the balloon can become entrapped inside the vessel after puncture or failure to deflate. Both these mishaps can cause serious consequences including a myocardial infarction, stroke, and death and may require surgery as the last resort. We report a case of an elderly dyspneic man presenting with anterior wall myocardial infarction. During PCI to the left anterior descending artery, the stent dislodged but was successfully retrieved with the twirling wire technique. During postdilatation of both stents with a noncompliant balloon, failure of deflation led to balloon entrapment and attempts to pull it resulted in fracture of the shaft. Successful recovery of the compromised apparatus was made by snaring the proximal wire end attached to the rest of the trapped equipment. The Twisted Guidewire technique was used to retrieve a dislodged stent, aided by a pre-positioned wire. Common retrieval methods include small-balloon, two-wire, and snaring techniques. Balloon shaft rupture is managed based on fragment location. Preventive measures include lesion preparation and guide catheter extensions. The simultaneous occurrence of stent dislodgement and balloon shaft fracture is rare and may relate to tortuous, calcified vessels.. The risk of rare, life-threatening PCI complications in complex cases necessitates stringent precautions and operator expertise in identifying and managing both common and rare events.

24 November 2023 in Frontiers in Neurology
Verified
Journal Article
Open access
KKKamran Ahmed Khan
Kamran Ahmed Khan
ILIrfan Amjad Lutfi
Irfan Amjad Lutfi
JSJehangir Ali Shah
Jehangir Ali Shah
SFSalman Farooq
Salman Farooq
SAShahnoor Ahmed
Shahnoor Ahmed
NQNadeem Qamar
Nadeem Qamar
Persistent primitive hypoglossal artery (PPHA) is a highly uncommon abnormal connection between the internal carotid artery (ICA) and vertebral artery (VA), with reported incidences ranging from 0.027 to 0.26%. Attempting endovascular intervention in such cases presents a considerable challenge as it carries a higher risk of embolization and other procedure-related complications that may affect a wide area of the brain. We present a case study involving the utilization of mechanical thrombectomy (MT) to treat an ischemic stroke in the M1 segment of the middle cerebral artery (MCA) despite the presence of PPHA. Performing mechanical thrombectomy in an anomalous vascular connection is feasible; however, it necessitates heightened vigilance, thorough knowledge of the anatomy, and utmost caution.

26 May 2021 in Pakistan Heart Journal
Verified
Journal Article
Closed access
PDF file
KKKamran Ahmed Khan
Kamran Ahmed Khan
MBMahesh Kumar Batra
Mahesh Kumar Batra
DKDileep Kumar
Dileep Kumar
Sajjad AliSajjad Ali
Sajjad Ali
VKVinesh Kumar
Vinesh Kumar
MKMusa Karim
Musa Karim
Objective: ST-segment elevation myocardial infarction (STEMI) at younger age though infrequent but very crucial entity, but there is dearth of available data, however, a rising trend has noticed recently in Asian countries. The aim was to see the territorial and clinical profile influence on overall outcomes of young individuals (≤35 years) with STEMI. Methodology: Patients with STEMI having age of ≤35 years during August 2020 to December 2020 were recruited and divided into left anterior descending artery (LAD)-culprit and non-LAD-culprit STEMI groups in this prospective observational study. Territorial angiographic and clinical characteristics were compared. Results: 1435 STEMI patients underwent coronary angiogram, 5.3% (94) were ≤35 years of age. LAD was culprit in 74.4% of STEMI mainly as a single vessel disease (SVD) involving the proximal segment as major territorial angiographic finding while 25.5% were non-LAD-culprit STEMI. Obesity, smoking, smokeless tobacco use especially gutka, were frequent in LAD-culprit group. In-hospital and at 3 months mortality was 2.1% (2) and 7.1% (5) respectively, all related to LAD territory. Rate of safe discharges and back to routine was 97.2% vs.100% and 70% vs.79.1% (72), respectively were comparable in both groups. Conclusion: LAD predominantly its proximal segment is the commonest culprit territory in patients with STEMI in youth with significant association to obesity, smoking and smokeless tobacco use especially gutka. LAD-culprit STEMI is the major territorial determinant for mortality and heart failure, however, overall clinical outcomes were reasonably good and comparable with non-LAD-culprit STEMI considering alive discharges and back to routine life.